BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Piché A. Malignant peritoneal effusion acting as a tumor environment in ovarian cancer progression: Impact and significance. World J Clin Oncol 2018; 9(8): 167-171 [PMID: 30622924 DOI: 10.5306/wjco.v9.i8.167]
URL: https://www.wjgnet.com/2218-4333/full/v9/i8/167.htm
Number Citing Articles
1
Caroline Elizabeth Ford, Bonnita Werner, Neville Frederick Hacker, Kristina Warton. The untapped potential of ascites in ovarian cancer research and treatmentBritish Journal of Cancer 2020; 123(1): 9 doi: 10.1038/s41416-020-0875-x
2
Corinna Steidel, Fanny Ender, Achim Rody, Nikolas von Bubnoff, Frank Gieseler. Biologically Active Tissue Factor-Bearing Larger Ectosome-Like Extracellular Vesicles in Malignant Effusions from Ovarian Cancer Patients: Correlation with Incidence of ThrombosisInternational Journal of Molecular Sciences 2021; 22(2): 790 doi: 10.3390/ijms22020790
3
Mariana Nunes, Sara Ricardo. Ovarian Cancer2022; : 27 doi: 10.36255/exon-publications-ovarian-cancer-malignant-ascites
4
Militsa Rakina, Anna Kazakova, Alisa Villert, Larisa Kolomiets, Irina Larionova. Spheroid Formation and Peritoneal Metastasis in Ovarian Cancer: The Role of Stromal and Immune ComponentsInternational Journal of Molecular Sciences 2022; 23(11): 6215 doi: 10.3390/ijms23116215
5
Marta Brunetti, Ioannis Panagopoulos, Ilyá Kostolomov, Ben Davidson, Sverre Heim, Francesca Micci. Mutation analysis and genomic imbalances of cells found in effusion fluids from patients with ovarian cancerOncology Letters 2020; 20(3): 2273 doi: 10.3892/ol.2020.11782
6
Sarai Tomás-Pérez, Julia Oto, Cristina Aghababyan, Raquel Herranz, Aitor Cuadros-Lozano, Eva González-Cantó, Bárbara Mc Cormack, Judith Arrés, María Castaño, Fernando Cana, Laura Martínez-Fernández, Núria Santonja, Rocío Ramírez, Alejandro Herreros-Pomares, Sarai Cañete-Mota, Antoni Llueca, Josep Marí-Alexandre, Pilar Medina, Juan Gilabert-Estellés. Increased levels of NETosis biomarkers in high-grade serous ovarian cancer patients’ biofluids: Potential role in disease diagnosis and managementFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1111344
7
Bonnita Werner, Nicole Yuwono, Jennifer Duggan, Dongli Liu, Catherine David, Sivatharsny Srirangan, Pamela Provan, Anna DeFazio, Vivek Arora, Rhonda Farrell, Yeh Chen Lee, Kristina Warton, Caroline Ford. Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancerGynecologic Oncology 2021; 162(3): 720 doi: 10.1016/j.ygyno.2021.06.028
8
薇 周. The Value of Ascites Cytology in the Diagnosis of Ovarian Malignant TumorsAdvances in Clinical Medicine 2023; 13(05): 7809 doi: 10.12677/ACM.2023.1351091
9
O. I. Aleshikova, N. A. Babaeva, E. V. Gerfanova, I. B. Antonova, V. O. Shender, A.  E. Babaeva, L. A. Ashrafyan. Ovarian cancer, malignant ascites and microenvironment. Literature reviewSechenov Medical Journal 2023; 14(2): 21 doi: 10.47093/2218-7332.2023.14.2.21-30
10
Pascale Ribaux, Aurore Britan, Gabriele Thumann, Florence Delie, Patrick Petignat, Marie Cohen. Malignant ascites: a source of therapeutic protein against ovarian cancer?Oncotarget 2019; 10(57): 5894 doi: 10.18632/oncotarget.27185
11
Bingsi Gao, Xingping Zhao, Pan Gu, Dan Sun, Xinyi Liu, Waixing Li, Aiqian Zhang, Enuo Peng, Dabao Xu. A nomogram model based on clinical markers for predicting malignancy of ovarian tumorsFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.963559